IR 820 dye encapsulated in polycaprolactone glycol chitosan: Poloxamer blend nanoparticles for photo immunotherapy for breast cancer

Materials Science and Engineering C

Volumn 57, Issue , 2015, Pages 321-327

  Kumar, Piyush ^a   Srivastava, Rohit ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

Biocompatibility; IR 820; Photothermal therapy; Poloxamer; Reactive oxygen species; TNF

Indexed keywords

BIOCOMPATIBILITY; CELL DEATH; CELLS; CHITIN; CHITOSAN; CYTOLOGY; CYTOTOXICITY; GLYCOLS; NANOPARTICLES; POLYCAPROLACTONE; SOLUTIONS; TRANSMISSION ELECTRON MICROSCOPY;

GLYCOL CHITOSAN; LASER TREATMENT; METASTATIC CANCERS; PHOTO-THERMAL; PHOTOIMMUNOTHERAPY; PHOTOTHERMAL THERAPY; POLOXAMER; REACTIVE OXYGEN SPECIES;

DISEASES;

CHITOSAN; GLYCOL; INDOCYANINE GREEN; IR 820; NANOCAPSULE; POLOXAMER; POLYCAPROLACTONE; POLYESTER; RADIOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE;

ANALOGS AND DERIVATIVES; BREAST NEOPLASMS; CHEMISTRY; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; MCF 7 CELL LINE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; TREATMENT OUTCOME; ULTRASTRUCTURE;

BREAST NEOPLASMS; CHITOSAN; COMBINED MODALITY THERAPY; GLYCOLS; HUMANS; IMMUNOTHERAPY; INDOCYANINE GREEN; MCF-7 CELLS; NANOCAPSULES; PHOTOCHEMOTHERAPY; POLOXAMER; POLYESTERS; RADIATION-SENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; TREATMENT OUTCOME;

EID: 84939243469     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2015.08.006     Document Type: Article

References (37)

1. J.H. Adair, M.P. Parette, E.I. Altinoʇlu, and M. Kester Nanoparticulate alternatives for drug delivery ACS Nano 4 2010 4967 4970
2. A. Mahapatro, and D.K. Singh Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines J. Nanobiotechnol. 9 2011 55
3. T.K. Dash, and V.B. Konkimalla Poly-ε-caprolactone based formulations for drug delivery and tissue engineering: a review J. Control. Release 158 2012 15 33
4. A. Kumari, S.K. Yadav, and S.C. Yadav Biodegradable polymeric nanoparticles based drug delivery systems Colloids Surf. B: Biointerfaces 75 2010 1 18
5. A.V. Kabanov, E.V. Batrakova, and V. Yu Pluronic block copolymers for overcoming drug resistance in cancer 54 2002 759 779
6. F. Yan, C. Zhang, Y. Zheng, L. Mei, L. Tang, C. Song, H. Sun, and L. Huang The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity Nanomed. Nanotechnol. Biol. Med. 6 2010 170 178
7. K. Toth, R.B. Wenby, and H.J. Meiselman Inhibition of polymer-induced red blood cell aggregation by poloxamer 188 Biorheology 37 2000 301 312
8. L. Mei, Y. Zhang, Y. Zheng, G. Tian, C. Song, D. Yang, H. Chen, H. Sun, Y. Tian, K. Liu, Z. Li, and L. Huang A novel docetaxel-loaded poly (ε-caprolactone)/pluronic F68 nanoparticle overcoming multidrug resistance for breast cancer treatment Nanoscale Res. Lett. 4 2009 1530 1539
9. P.N. Gupta, S. Jain, C. Nehate, N. Alam, V. Khare, R.D. Dubey, A. Saneja, S. Kour, and S.K. Singh Development and evaluation of paclitaxel loaded PLGA:poloxamer blend nanoparticles for cancer chemotherapy Int. J. Biol. Macromol. 69C 2014 393 399
10. P. Caaman, A. Sa, and F. DomI PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery Society 2005 271 278
11. I. Tsoneva, I. Iordanov, A.J. Berger, T. Tomov, B. Nikolova, N. Mudrov, and M.R. Berger Electrodelivery of drugs into cancer cells in the presence of poloxamer 188 J. Biomed. Biotechnol. 2010 2010
12. H. Koo, K.H. Min, S.C. Lee, J.H. Park, K. Park, S.Y. Jeong, K. Choi, I.C. Kwon, and K. Kim Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery J. Control. Release 172 2013 823 831
13. G. Bajaj, G. William, V. Alstine, and Y. Yeo Zwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine release 7 2012 e30899
14. S. Kim, D.J. Lee, D.S. Kwag, U.Y. Lee, Y.S. Youn, and E.S. Lee Acid pH-activated glycol chitosan/fullerene nanogels for efficient tumor therapy Carbohydr. Polym. 101 2014 692 698
15. R.N. Mitra, Z. Han, M. Merwin, M. Al Taai, S.M. Conley, and M.I. Naash Synthesis and characterization of glycol chitosan DNA nanoparticles for retinal gene delivery ChemMedChem 9 2014 189 196
16. J. Young, S. Song, S. Jin, S. Park, K. Kim, M. Goo, S. Son, H. Koo, I. Chan, J. Hoon, S. Young, S. Hwa, and K. Kim Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance J. Control. Release 198 2015 1 9
17. S. Lee, S.W. Kang, J.H. Ryu, J.H. Na, D.E. Lee, S.J. Han, C.M. Kang, Y.S. Choe, K.C. Lee, J.F. Leary, K. Choi, K.H. Lee, and K. Kim Tumor-homing glycol chitosan-based optical/PET dual imaging nanoprobe for cancer diagnosis Bioconjug. Chem. 25 2014 601 610
18. J. Rhee, O.K. Park, A. Lee, D.H. Yang, and K. Park Glycol Chitosan-based Fluorescent Theranostic Nanoagents for Cancer Therapy 2014 6038 6057
19. C.S., R., J. Kumar, V., R., M., V., and A. Abraham Laser immunotherapy with gold nanorods causes selective killing of tumour cells Pharmacol. Res. 65 2012 261 269
20. P. Zhao, M. Zheng, C. Yue, Z. Luo, P. Gong, G. Gao, Z. Sheng, C. Zheng, and L. Cai Improving drug accumulation and photothermal efficacy in tumor depending on size of ICG loaded lipid-polymer nanoparticles Biomaterials 35 2014 6037 6046
21. M. Zheng, C. Yue, Y. Ma, P. Gong, P. Zhao, C. Zheng, Z. Sheng, P. Zhang, Z. Wang, and L. Cai Single-step assembly of DOX/ICG loaded lipid-polymer nanoparticles for highly effective chemo-photothermal combination therapy ACS Nano 7 2013 2056 2067
22. M. Zheng, P. Zhao, Z. Luo, P. Gong, C. Zheng, P. Zhang, C. Yue, D. Gao, Y. Ma, and L. Cai Robust ICG theranostic nanoparticles for folate targeted cancer imaging and highly effective photothermal therapy ACS Appl. Mater. Interfaces 6 2014 6709 6716
23. W. Guo, L. Zhang, J. Ji, W. Gao, J. Liu, and M. Tong Breast cancer sentinel lymph node mapping using near-infrared guided indocyanine green in comparison with blue dye Tumour Biol. 35 4 2014 10.1007/s13277-013-1399-2
24. V. Melikian, J.D. Eddy, and A. Paton The stimulant effect of drug on indocyanine green clearance by liver Gut 13 1972 755
25. A. Fernandez-Fernandez, R. Manchanda, T. Lei, D.A. Carvajal, Y. Tang, S.Z.R. Kazmi, and A.J. McGoron Comparative study of the optical and heat generation properties of IR820 and indocyanine green Mol. Imaging 11 2012 99 113
26. S. Srinivasan, R. Manchanda, A. Fernandez-Fernandez, T. Lei, and A.J. Mcgoron Near-infrared fluorescing IR820-chitosan conjugate for multifunctional cancer theranostic applications J. Photochem. Photobiol. B Biol. 119 2013 52 59
27. P. Huang, P. Rong, A. Jin, X. Yan, M.G. Zhang, J. Lin, H. Hu, Z. Wang, X. Yue, W. Li, G. Niu, W. Zeng, W. Wang, K. Zhou, and X. Chen Dye-loaded ferritin nanocages for multimodal imaging and photothermal therapy Adv. Mater. 2014 6401 6408
28. A. Fernandez, R. Manchanda, and T. Lei Covalent IR820-PEG-diamine nanoconjugates for theranostic applications in cancer Int. J. Nanomedicine 2014 4631 4648
29. P. Kumar, and R. Srivastava IR 820 stabilized multifunctional polycaprolactone glycol chitosan composite nanoparticles for cancer therapy RSC Adv. 5 2015 56162 10.1039/C5RA05997F
30. A.P. Ranjan, K. Zeglam, A. Mukerjee, S. Thamake, and J.K. Vishwanatha A sustained release formulation of chitosan modified PLCL:poloxamer blend nanoparticles loaded with optical agent for animal imaging Nanotechnology 22 2011 295104
31. L. Minai, D. Yeheskely-Hayon, and D. Yelin High levels of reactive oxygen species in gold nanoparticle-targeted cancer cells following femtosecond pulse irradiation Sci. Rep. 3 2013 2146
32. K. Fuller, R. Issels, and D. Slosman Eur. J. Cancer 30 1994 1884 1891
33. B.V. Harmon, Y.S. Takano, C.M. Winterford, and G.C. Gobé Int. J. Radiat. Biol. 59 1991 489 501
34. D.K. Chatterjee, P. Diagaradjane, and S. Krishnan Ther. Deliv. 2 2011 1001 1014
35. S.M. Moghimi, A.C. Hunter, C.M. Dadswell, S. Savay, C.R. Alving, and J. Szebeni Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. a protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels Biochim. Biophys. Acta 1689 2004 103 113
36. R. Chen, X. Wang, X. Yao, X. Zheng, J. Wang, and X. Jiang Near-IR-triggered photothermal/photodynamic dual-modality therapy system via chitosan hybrid nanospheres Biomaterials 34 2013 8314 8322
37. M.E. Burow, C.B. Weldon, Y. Tang, G.L. Navar, S. Krajewski, J.C. Reed, T.G. Hammond, S. Clejan, and B.S. Beckman Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants Cancer Res. 58 1998 4940 4946